Clearstead Advisors, LLC Care Dx, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 111 shares of CDNA stock, worth $1,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111Holding current value
$1,686% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
210Shares Held
55.8MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$80.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$74.6 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.6 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$37 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$33.1 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $812M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...